Editor's Note: Green and red arrows refer to intraday stock price movement. NEW YORK ( TheStreet) -- CHANGE IN RATINGS Advanced Micro ( AMD - Get Report)rated new Hold at Jefferies. $7.50 price target. Company has attractive growth prospects, but a vacuum in the CEO position. Ametek ( AME - Get Report) rated new Neutral at UBS. $47 price target. Valuation near full at present prices. AutoNation ( AN - Get Report) downgraded at Wells from Market Perform to Underperform. New vehicle sales have been lower across the industry in May and June. Avery Dennison ( AVY - Get Report) downgraded at Baird from Outperform to Neutral. $39 price target. Disappointing 2Q pre-announcement and related lowering of FY11 expectations. Check Point Software ( CHKP - Get Report) upgraded at BofA/Merrill from Neutral to Buy. Estimates also boosted. $71 price target. Carlisle Companies ( CSL) upgraded at FBR from Underperform to Market Perform, FBR Capital Markets said. $45 price target. Commercial construction market is improving and raw materials costs have pulled back. Quest Diagnostics ( DGX - Get Report) downgraded at Jefferies from Buy to Hold. $64 price target. Healthcare services could remain under pressure, as unemployment figures remain high. Edwards Lifesciences ( EW) rated new Neutral at Credit Suisse. Valuation call, based on a $99 price target. Fusion-io ( FIO) rated new Outperform at Credit Suisse. $40 price target. Company is leveraged to continued demand from datacenters. Fusion-io ( FIO) rated new Neutral at JP Morgan. Valuation call, based on a $35 price target. Hershey Foods ( HSY - Get Report) rated new Neutral at Ticonderoga Securities. Valuation call, as the stock is pricing in market share gains. IDEX Corp. ( IEX) upgraded at UBS from Neutral to Buy. $52 price target. Pullback offers attractive entry point. Intel ( INTC) rated new Hold at Jefferies. $25 price target. Company is leveraged to decelerating PC demand. Kellogg ( K) rated new Neutral at Ticonderoga. Company is in the midst of an earnings transition. Nuvasive ( NUVA) upgraded at Baird from Neutral to Outperform. $42 price target. Spine market has likely bottomed out. Scotts Miracle-Gro ( SMG) downgraded at BMO to Market Perform. $50 price target. MAT28 is facing increased scrutiny. Thoratec ( THOR) rated new Outperform at Credit Suisse. $43 price target. Company can continue to grow its market share across the globe. Texas Instruments ( TXN) rated new Buy at Jefferies. $38 price target. NSM purchase should allow the company to grow within the analog market. VCA Antech ( WOOF) upgraded at BofA/Merrill from Underperform to Buy. $28 price target. Recent acquisitions should help augment growth. End of report.